Literature DB >> 7878393

Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation.

T Odergren1, A Tollbäck, J Borg.   

Abstract

Twenty patients with cervical dystonia were treated during one year with repeated intramuscular injections of botulinum toxin. The outcome was evaluated comparing subjective global rating with relative changes in degree of pain on the Visual analogue scale (VAS), degree of dysfunction due to dystonia, and quality of life according to the Nottingham health profile (NHP). Objective measurement of dystonic position and movement ability was performed using a goniometer, semiquantitatively noted as scores according to Fahn and Tsui. Before treatment, the degree of impaired life quality on the NHP did not correlate with the Tsui score of dystonic posture, but significantly with the Fahn score (p < 0.01) which also includes data on pain. Significant improvement after treatment was seen for all parameters (p < 0.05). Global subjective rating correlated significantly with improved posture according to the Tsui score (p < 0.05), but not with reduced pain or degree of dysfunction. The results suggest that the efficacy of botulinum toxin in cervical dystonia is best evaluated using a combination of the VAS for pain and the Tsui score for dystonic posture and movement ability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7878393

Source DB:  PubMed          Journal:  Scand J Rehabil Med        ISSN: 0036-5505


  7 in total

1.  Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia.

Authors:  R Hilker; M Schischniaschvili; M Ghaemi; A Jacobs; J Rudolf
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

2.  A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia.

Authors:  T Odergren; H Hjaltason; S Kaakkola; G Solders; J Hanko; C Fehling; R J Marttila; H Lundh; S Gedin; I Westergren; A Richardson; C Dott; H Cohen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

3.  Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Authors:  R C Dodel; A Kirchner; R Koehne-Volland; G Künig; A Ceballos-Baumann; M Naumann; A Brashear; H P Richter; T D Szucs; W H Oertel
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

Review 4.  Botulinum toxin therapy for myofascial pain disorders.

Authors:  Amy M Lang
Journal:  Curr Pain Headache Rep       Date:  2002-10

5.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

6.  Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.

Authors:  J Müller; J Wissel; G Kemmler; B Voller; T Bodner; A Schneider; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 7.  Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.

Authors:  Wolfgang H Jost; Harald Hefter; Andrea Stenner; Gerhard Reichel
Journal:  J Neural Transm (Vienna)       Date:  2012-08-17       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.